Management of Insomnia and Nausea/Vomiting During Pregnancy

Introduction to Medication Safety During Pregnancy

The safety of antihistamines during pregnancy has been confirmed through large birth registries, case-control studies, and cohort studies, but the choice of antihistamine should be based on established safety profiles 1
All medication use during pregnancy should prioritize the lowest effective dose to minimize potential risks 2
The most critical time for potential congenital malformations is the first trimester during organogenesis, and antihistamine use should be carefully considered during this period 1

Intranasal corticosteroids, such as budesonide (FDA Pregnancy Category B), are a safer treatment option for allergic rhinitis during pregnancy, as recommended by the American College of Allergy, Asthma, and Immunology 1
Sodium cromolyn (FDA Pregnancy Category B) is also a recommended option for treating allergic rhinitis during pregnancy 1
Well-studied antihistamines with established safety profiles, such as loratadine and cetirizine, are preferred over those with limited data like ebastine for treating allergic rhinitis during pregnancy 1

The American College of Obstetricians and Gynecologists recommends doxylamine 25mg at bedtime as a second-line treatment for insomnia during pregnancy, with a favorable safety profile based on extensive clinical experience and research data 1
First-generation antihistamines like chlorpheniramine have extensive safety data from long-term use, though they have sedative effects, and are recommended for use during pregnancy 1
Second-generation antihistamines with more established pregnancy safety data, such as loratadine and cetirizine, should be preferred over those with limited data like ebastine 1
Diphenhydramine, while frequently used during pregnancy, has been associated with cleft palate development in some studies, and its use should be approached with caution 1
Hydroxyzine should be used cautiously during the first trimester based on animal data, and oral decongestants should be avoided during the first trimester due to possible associations with congenital malformations 1
The American Academy of Allergy, Asthma, and Immunology recommends avoiding ebastine during pregnancy due to insufficient safety data and the availability of better-studied antihistamine alternatives 1

Doxylamine does not have a specific safety concern associated with cleft palate development, unlike diphenhydramine, according to the American Academy of Allergy, Asthma, and Immunology 1
There are insufficient human pregnancy safety data for ebastine compared to other antihistamines, with limited data on its use during pregnancy 1